{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:45:46Z","timestamp":1771627546408,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Youth Fund of Hainan Cancer Hospital","award":["(No.3 of 2022)"],"award-info":[{"award-number":["(No.3 of 2022)"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,15]]},"abstract":"<jats:p>Cervical cancer is the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women. This study explored the effectiveness and safety of ultrasound-CT guided 3D intracavitary and interstitial brachytherapy (US-CT-3D-IGBT) in the treatment of larger cervical cancer with bleeding. A retrospective study was conducted on 31 patients with larger cervical squamous cell carcinoma (tumor short diameter &gt;4\u2009cm) with vaginal bleeding. US-CT-3D-IGBT was used to deliver a single high-dose prescription of high-risk clinical target volume (HR-CTV) 1000 to 1200 centigray (cGy) to the cervical tumor, followed by conventional intensity-modulated radiation therapy (IMRT) synchronous chemoradiotherapy (45\u201350 gray (Gy)\/25\u201328 fraction(f)) with weekly cisplatin 25\u2009mg\/m<jats:sup>2<\/jats:sup>. After external radiotherapy, simple intracavitary brachytherapy (BT) combined with manual interstitial BT was administered at 30 Gy\/5F or 28 Gy\/4F. Within 24 hours after high-dose 3D-IGBT, bleeding stopped in 2 patients (6.4%), and bleeding was reduced in a total of 11 patients (35.4%) within 48 hours. A total of 29 patients achieved hemostasis within 72 hours, with an effective rate of 93.5%. The remaining 2 patients reached the clinical hemostasis requirement on the 4th and 5th day. All patients experienced a significant reduction in vaginal bleeding after the initial BT, with an average reduction of 66\u2009mL (160\u201320\u2009mL). US-CT-3D-IGBT is effective in rapidly controlling bleeding in patients with larger cervical cancer (tumor short diameter\u2005&gt;4\u2009cm), and the treatment is relatively safe and feasible.<\/jats:p>","DOI":"10.1097\/md.0000000000034904","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:23:26Z","timestamp":1694827406000},"page":"e34904","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Observation of hemostatic effectiveness and safety of ultrasound-CT guided 3D intracavitary and interstitial brachytherapy in the treatment of larger cervical cancer with bleeding: A retrospective study"],"prefix":"10.1097","volume":"102","author":[{"given":"Yuefeng","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Radiotherapy Oncology, Hainan Cancer Hospital, Haikou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, Hainan Cancer Hospital, Haikou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiophysics, Hainan Cancer Hospital, Haikou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0678-8632","authenticated-orcid":false,"given":"Yunxiu","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy Oncology, Hainan Cancer Hospital, Haikou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/1117-1936.181441","article-title":"Cisplatin chemotherapy for haemostasis in bleeding cervical cancer: experience from a resource-poor setting.","volume":"17","author":"Adewuyi","year":"2010","journal-title":"Niger Postgrad Med J"},{"key":"R3-20250504","first-page":"CD011000","article-title":"Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.","volume":"3","author":"Eleje","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20250504","first-page":"329","article-title":"Research progress on tumor angiogenesis and tumor infiltration and metastasis.","volume":"3","author":"Jiang","year":"2003","journal-title":"Cancer Prevent Treat"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brachy.2015.12.003","article-title":"Why brachytherapy boost is the treatment of choice for most women with locally advanced cervical carcinoma?","volume":"15","author":"Al Feghali","year":"2016","journal-title":"Brachytherapy"},{"key":"R6-20250504","first-page":"4165","article-title":"Imaging-guided brachytherapy for locally advanced cervical cancer: the main process and common techniques.","volume":"10","author":"Liu","year":"2020","journal-title":"Am J Cancer Res"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/0360-3016(86)90130-6","article-title":"1000 cGy single dose palliation for advanced carcinoma of the cervix or endometrium.","volume":"12","author":"Halle","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ijgc-00009577-200201000-00003","article-title":"High dose ratio (HDR) cervical ring applicator to control bleeding from cervical carcinoma.","volume":"12","author":"Grigsby","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.radonc.2011.01.009","article-title":"Palliative radiotherapy for cervical carcinoma, a systematic review.","volume":"98","author":"van Lonkhuijzen","year":"2011","journal-title":"Radiother Oncol"},{"key":"R10-20250504","first-page":"462","article-title":"Efficacy and safety analysis of high-dose Brachytherapy for the treatment of massive bleeding in patients with giant cervical cancer.","volume":"26","author":"Wang","year":"2020","journal-title":"Thromb Haemost"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ijgc-2021-003056","article-title":"Image-guided brachytherapy in cervical cancer including fractionation.","volume":"32","author":"Sturdza","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semradonc.2020.05.008","article-title":"Evidence-based dose planning aims and dose prescription in image-guided brachytherapy combined with radiochemotherapy in locally advanced cervical cancer.","volume":"30","author":"Tanderup","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5603\/EP.a2019.0036","article-title":"Is ultrasound combined with computed tomography useful for distinguishing between primary thyroid lymphoma and Hashimoto\u2019s thyroiditis?","volume":"70","author":"Luo","year":"2019","journal-title":"Endokrynol Pol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3802\/jgo.2014.25.3.206","article-title":"Ultrasound guided conformal brachytherapy of cervix cancer: survival, patterns of failure, and late complications.","volume":"25","author":"Narayan","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"R15-20250504","first-page":"6146901","article-title":"Combined application of ultrasound and CT increased diagnostic value in female patients with pelvic masses.","author":"Liu","year":"2016","journal-title":"Comput Math Methods Med"},{"key":"R16-20250504","first-page":"18","article-title":"Clinical study of simultaneous radiotherapy with capecitabine for middle and late stage cervical cancer in the elderly.","volume":"33","author":"Li","year":"2017","journal-title":"Chin Commun Phys"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobi.","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-20250504","first-page":"193","article-title":"Observation of the hemostatic effect of simultaneous integrated boost radiotherapy on massive cervical cancer in the tumor center.","volume":"3","author":"Ma","year":"2019","journal-title":"Chin J Radiat Oncol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/cancers14051257","article-title":"3D-image-guided multi-catheter interstitial brachytherapy for bulky and high-risk stage IIB-IVB cervical cancer.","volume":"14","author":"Kokabu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2013.01.010","article-title":"Clinical feasibility of combined intracavitary\/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem\/ring applicator in situ and virtual preplanning of the interstitial component.","volume":"107","author":"Fokdal","year":"2013","journal-title":"Radiother Oncol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/gyno.2001.6233","article-title":"10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri.","volume":"82","author":"Onsrud","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R27-20250504","first-page":"462","article-title":"Efficacy and safety analysis of high-dose rate afterloading in the treatment of massive bleeding in patients with giant cervical cancer.","volume":"26","author":"Wang","year":"2020","journal-title":"Thromb Hemost"},{"key":"R28-20250504","first-page":"935","article-title":"Carcinoma of the cervix: radiotherapy. Radiation substances and after-loading: low and high dose-rates.","volume":"66","author":"Snelling","year":"1973","journal-title":"Proc R Soc Med"},{"key":"R29-20250504","first-page":"315","article-title":"Progress of research on intestinal outline and dose-volume limitation of intensity modulation and 3D conformal radiotherapy for pelvic tumors.","volume":"4","author":"Xu","year":"2021","journal-title":"Chin J Radiat Med Protect"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.21873\/invivo.12177","article-title":"Treatment outcome of the combination therapy of high-dose rate intracavitary brachytherapy and intensity-modulated radiation therapy with central-shielding for cervical cancer.","volume":"34","author":"Mukai","year":"2020","journal-title":"In Vivo"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.semradonc.2019.02.010","article-title":"Image-guided adaptive radiotherapy in cervical cancer.","volume":"29","author":"Tan","year":"2019","journal-title":"Semin Radiat Oncol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1046087","DOI":"10.3389\/fonc.2022.1046087","article-title":"Prognostic impact of tumor size reduction assessed by magnetic resonance imaging after radiochemotherapy in patients with locally advanced cervical cancer.","volume":"12","author":"Cordoba","year":"2022","journal-title":"Front Oncol"},{"key":"R33-20250504","first-page":"876","article-title":"Current study on intertissue interpolation radiotherapy for cervical cancer.","volume":"43","author":"Liu","year":"2016","journal-title":"Cancer Prevent Treat"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.gore.2019.07.009","article-title":"Comparison of clinical outcome between computed tomography-based image-guided brachytherapy and two-dimensional-based brachytherapy for cervical cancer.","volume":"29","author":"Imano","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2021.05.010","article-title":"IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer.","volume":"160","author":"Mahantshetty","year":"2021","journal-title":"Radiother Oncol"},{"key":"R36-20250504","first-page":"CD011000","article-title":"Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.","volume":"2015","author":"Eleje","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R37-20250504","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies;.","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American brachytherapy society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles.","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1080\/02841860802266698","article-title":"A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.","volume":"47","author":"Assenholt","year":"2008","journal-title":"Acta Oncol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijrobp.2006.01.036","article-title":"The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.","volume":"65","author":"Kirisits","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034904","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:44:36Z","timestamp":1746326676000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":37,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034904","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]}}}